BNR insider buying and SEC filings, explained
Burning Rock Biotech Ltd · CIK 1792267
Tracked: Forms 3/4/5, 8-K, NT · Limited coverage: files 6-K/20-F, not covered in v1 · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Services-Medical Laboratories
Insider activity in the last 12 months
Bought
$11.6M
Insiders who bought
1
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Jun 11–26, 2026 | Purchase (code P) | Yusheng Han (Director) bought 731,410 shares between Jun 11 and Jun 26 at about $8.45 ($6.2M), reported as a purchase (code P). Holdings up 4% to 18,404,086 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 2, 2026 |
| Mar 31, 2026 | Purchase (code P) | Yusheng Han (Director) bought 314,870 shares at about $17.36 ($5.5M), reported as a purchase (code P). Holdings up 2% to 17,672,676 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Apr 2, 2026 |
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow BNR in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.